Is female sex a risk modifier rather than a risk factor for stroke in patients with atrial fibrillation?
Patients with atrial fibrillation
Use of CHA2DS2-VA score (excluding sex category criterion) for initial oral anticoagulant treatment decisions
Strokehard clinical
Initial decisions on oral anticoagulation in atrial fibrillation could be guided by the CHA2DS2-VA score, treating female sex as a risk modifier rather than a primary risk factor.
Female sex is a risk modifier for stroke in patients with atrial fibrillation. Initial decisions on oral anticoagulant treatment could be guided by a CHA2DS2-VA score (ie, excluding the sex category criterion), but the Sc risk component modifies and accentuates stroke risk in women who would have been eligible for oral anticoagulant treatment on the basis of ≥2 additional stroke risk factors.
Building similarity graph...
Analyzing shared references across papers
Loading...
Peter Brønnum Nielsen
Flemming Skjøth
Thure Filskov Overvad
Circulation
University of Birmingham
Aalborg University
Aalborg University Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Nielsen et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69d01832ac64bb106819e720 — DOI: https://doi.org/10.1161/circulationaha.117.029081